Zydus Lifesciences Ltd. Conference Calls and Earnings Call Transcripts

Zydus Lifesciences Ltd. Conference Calls and Earnings Call Transcripts: Get insights into company performance, financials, capex plans, and more.

Quarter

Conference/Earnings Calls Alerts

Zydus Lifesciences Ltd.

10 Aug 2022

844.40

-1.71%

Earnings Call

Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

BSE India

Audio recording of the Investor call on financial results for quarter ended June 30, 2022

Zydus Lifesciences Ltd.

26 May 2022

844.40

-1.71%

Earnings Call

Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

BSE India

The Transcript of the Company's Q4 FY22 post results Investors' call held at 4:30 p.m. on May 20, 2022

Zydus Lifesciences Ltd.

20 May 2022

844.40

-1.71%

Earnings Call

Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

BSE India

The audio recording of the Company's Investor Call to discuss the financial results for the quarter and year ended March 31, 2022

Zydus Lifesciences Ltd.

03 Feb 2022

844.40

-1.71%

Earnings Call for Q3FY22 of Cadila Healthcare

Conference Call with Cadila Healthcare Management and Analysts on Q3FY22 Performance and Outlook. Listen to the full earnings transcript.

Zydus Lifesciences Ltd.

22 Nov 2021

844.40

-1.71%

Earnings Call

CADILA HEALTHCARE LTD. - 532321 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BSE India

The transcript of the Company's Q2 FY22 post results conference call held at 4:00 p.m. on October 29, 2021.

Zydus Lifesciences Ltd.

03 Sep 2021

844.40

-1.71%

Earnings Call

Cadila Healthcare Ltd - 532321 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

BSE India

Transcript of the investor call arranged on August 23, 2021 to discuss about the receipt of Emergency Use Authorization of ZyCoV-D vaccine

Zydus Lifesciences Ltd.

23 Aug 2021

844.40

-1.71%

Conference Call with Cadila Healthcare: Emergency Use Approval of Covid Vaccine

Conference Call with Cadila Healthcare Management and Analysts on Emergency Approval (EUA) of Zycov-D Vaccine against Coronavirus. Listen to the full transcript.

Zydus Lifesciences Ltd.

20 Aug 2021

844.40

-1.71%

Earnings Call

CADILA HEALTHCARE LTD. - 532321 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BSE India

Transcript of the conference call held on August 11 2021 post Q1 results

Zydus Lifesciences Ltd.

11 Aug 2021

844.40

-1.71%

Earnings Call for Q1FY22 of Cadila Healthcare

Conference Call with Cadila Healthcare Management and Analysts on Q1FY22 Performance and Outlook. Listen to the full earnings transcript.

Zydus Lifesciences Ltd.

27 May 2021

844.40

-1.71%

Earnings Call for Q4FY21 of Cadila Healthcare

Conference Call with Cadila Healthcare Management and Analysts on Q4FY21 Performance and Outlook. Listen to the full earnings transcript.

No results found